Evidence map›Paper›PMID 20405335›Full record

ArticleJournal of general internal medicine2010

Time to depression treatment in primary care among HIV-infected and uninfected veterans.

Dina Hooshyar, Joseph Goulet, Lydia Chwastiak, Steven Crystal, Cynthia Gibert, Kristin Mattocks, David Rimland, Maria Rodriguez-Barradas, Amy C Justice, VACS Project Team

Open access · bronzeAbstract readComparative StudyMulticenter Study
In one paragraph

Article in Journal of general internal medicine, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Moving medical advances from prototype into practice.Journal of general internal medicine · 2010
    Article
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Dina HooshyarYale University School of Medicine, New Haven, CT, USA.
Joseph Goulet
Lydia Chwastiak
Steven Crystal
Cynthia Gibert
Kristin Mattocks
David Rimland
Maria Rodriguez-Barradas
Amy C Justice
VACS Project Team
Yale University · USMichael E. DeBakey VA Medical Center · USRutgers, The State University of New Jersey · USEmory University · USGeorge Washington University · US

Funding

Alcohol Associated Outcomes Among HIV+/- Aging VeteransU10AA013566 · NIAAA · YALE UNIVERSITY · PI JUSTICE, AMY CAROLINE · 2006 to 2010
$12.7M
Alcohol Associated Outcomes Among HIV+/-Aging VeteransU01AA013566 · NIAAA · YALE UNIVERSITY · PI JUSTICE, AMY CAROLINE · 2002 to 2005
$10.1M
MEDIATORS OF AGE ASSOCIATED OUTCOMES IN HIV INFECTIONK23AG000826 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI JUSTICE, AMY CAROLINE · 1998 to 2002
$456k
NIAAA NIH HHS U01 AA013566NIAAA NIH HHS U01 AA 13566NIAAA NIH HHS U10 AA013566NIAAA NIH HHS U10 AA 13566NIA NIH HHS K23 AG00826
6 · The paper itself

Abstract

backgroundMultiple factors, including patient characteristics, competing demands, and clinic type, impact delivery of depression treatment in primary care.

objectiveAssess whether depression severity and HIV serostatus have a differential effect on time to depression treatment among depressed patients receiving primary care at Infectious Disease or General Medicine clinics.

designMulticenter prospective cohort, (Veterans Aging Cohort Study), comparing HIV-infected to uninfected patients. PARTICIPANTS AND MEASURES: The total cohort consisted of 3,239 HIV-infected and 3,227 uninfected patients. Study inclusion criteria were untreated depressive symptoms, based on a Patient Health Questionnaire (PHQ-9) score of greater than 9, and no antidepressants or mental health visits in the 90 days prior to PHQ-9 assessment. Treatment was defined as antidepressant receipt or mental health visit within 90 days following PHQ-9 assessment. Depression severity based on PHQ-9 scores was defined as mild-moderate (greater than 9 to 19) and severe (20 or greater). Kaplan-Meier curves were used to estimate time to treatment by depression severity and HIV serostatus. Cox proportional hazards methods adjusted for covariates were used. KEY

resultsOverall, 718 (11%) of the cohort met inclusion criteria, 258 (36%) of whom received treatment. Median time to treatment was 7 days [95% confidence interval (CI) = 4, 13] and was shortest for severely depressed HIV-infected patients (0.5 days; 95% CI = 0.5, 6, p = 0.04). Compared to mildly-moderately depressed uninfected patients, severely depressed HIV-infected patients were significantly more likely to receive treatment [adjusted hazard ratio (HR) 1.67, 95% CI = 1.07, 2.60), whereas mildly-moderately depressed HIV-infected patients (adjusted HR 1.10, 95% CI = 0.79, 1.52) and severely depressed uninfected patients (adjusted HR 0.93, 95% CI = 0.60, 1.44) were not.

conclusionsIn this large cohort, time to primary care treatment of depression was shortest among severely depressed HIV-infected patients. Regardless of HIV serostatus, if depression was not treated on the assessment day, then it was unlikely to be treated within a 90-day period, leading to the majority of depression being untreated.

Indexed as

Cohort StudiesDepressive DisorderFemaleHIV InfectionsHumansMaleMiddle AgedPrimary Health CareProspective StudiesTime FactorsTreatment OutcomeVeterans

Identifiers

PMID20405335
PMCPMC2881956
OpenAlexW2060300545

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.